EDIT

#3022
Editas Medicine, Inc. Common Stock
2.20
+5.26%
Secteur:
Base:
Devise de Profit:
Range quotidien
2.20
2.20
Range Annuel
0.91
4.54
Changement quotidien
+5.26%
Changement Mensuel
+3.29%
Evolution sur 6 mois
-18.52%
Changement Annuel
+22.91%
Clôture Précédente
2.09
Open
2.20
Bid
Ask
Low
2.20
High
2.20
Volume
56
Open full chart

Financials

Overview Relevé Statistics Dividends
Quarterly Annual
Income statement Balance sheet Cash flow
Value Q3, 24Q4, 24Q1, 25Q2, 25Q3, 25 TTM

Editas Medicine Inc

Editas Medicine, Inc., is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado.

Nouvelles